Interferon alfa-2a Completed Phase 3 Trials for Behçet's Disease / Uveitis Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT03209219Interferon α2a Versus Cyclosporine for Refractory Behçet's Disease Uveitis